Home » Newsletters » BioWorld Science

BioWorld Science

March 16, 2010

View Archived Issues

Memory Pharmaceuticals claims novel 5-HT6 receptor ligands

Novel MIF inhibitors identified by Yale University scientists for cancer therapy

Phase II data support superiority of OvPlex to CA-125 for diagnosis ovarian cancer

Array BioPharma claims novel Pim kinase inhibitors

GlaxoSmithKline presents new interferon inducers

Schering-Plough and Southern Research Institute claim new antivirals

Sirtris Pharmaceuticals presents novel SIRT modulators

Amgen patents novel Na(V)1.7 sodium channel blockers

Cilostazol may benefit patients with acute ischemic stroke

Array Biopharma presents new D2 receptor antagonists for allergic disease

Paricalcitol improves albuminuria in diabetic nephropathy

Eisai and Johns Hopkins to collaborate on development GCPII inhibitors

Xoma initiates phase II trial of XOMA-052 in type 1 diabetes

FDA grants orphan drug status to BioSante's GVAX pancreatic cancer vaccine

Inspire Pharmaceuticals reports phase II data on Azasite for blepharitis

Savient resubmits Krystexxa BLA for chronic gout to FDA

FDA requests additional information regarding Afrezza NDA for hyperglycemia in diabetes

MicuRx files IND for MRX-I antibiotic in China

UCB presents full-year results 2009

Amylin, Lilly and Alkermes receive FDA's complete response letter on once-weekly exenatide

Bio-Path receives FDA approval for clinical evaluation liposomal Grb-2 in cancer

FDA adds boxed warning to Plavix for reduced effectiveness in poor metabolizers of the drug

Revolade approved in Europe for thrombocytopenia in ITP

Orexigen and Patheon enter into exclusive manufacturing agreement for Contrave

Sigma-Aldrich to sell Pfizer's small-molecule compounds to researchers

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...